Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapencarium in Lipedema and Dercum's Disease
NCT03492840Phase 2Completed
- Sponsor
- Raziel Therapeutics
- Start
- Jun 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tapencarium in lipedema, Dercum's disease, sponsored by Raziel Therapeutics. Started Jun 2018; status: completed.
02
Drugs
Tapencarium
03
Conditions
lipedemaDercum's disease
Beyond the preview
Go deeper on NCT03492840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03492840.